Treatment of Cough and Dyspnea due to Acute Bronchitis by Plaster for Cough and Dyspnea-A Report of 735 Cases

In the light of the theory of treating the internal disease externally, an externally used plaster for treating cough and dyspnea due to acute bronchitis (Ke Chuan Yi Tie Kang [symbol: see text]-[symbol: see text]) was successfully applied to 735 cases of acute bronchitis (the treatment group), with the other 423 cases treated with routine western drugs as controls. The results showed that the cure rate in the treatment group was significantly higher than that in the control group (P < 0.01); and that in the treatment group, the cure rate for the wind-cold type of acute bronchitis was significantly higher than that for the wind-heat type of acute bronchitis (P < 0.01).     

Clinical Observation in 86 Cases of Acne Vulgaris Treated with Compound Oldenlandis Mixture

86 cases of acne vulgaris were treated with Fu Fang She She Cao He Ji (复方蛇舌草合剂 CompoundPrepared from Chinese Angelica and Flavescent Sophora Root) as the controls, to observe the therapeuticeffect of the former. The results showed that the cure plus markedly effective rate was 73.26% in thetreatment group, and 47.06% in the control group, with a significant difference in the cure plus markedlyeffective rate between the two groups (P＜0.01), and also in the total effective rate between the two groupssignificant (P＜0.05). It may be concluded that the Compound Oldenlandis Mixture is a better agent for theillness.     

A double blind observation for therapeutic effects of the tong luo kai bi tablets on rheumatoid arthritis.

The therapeutic effects of the Tong Luo Kai Bi Tablets [symbol: see text] in 120 patients with rheumatoid arthritis were observed in this clinical trial by the randomized double blind method. Both the observed group and the control group each had 60 patients. In the observed group treated with the Tong Luo Kai Bi Tablets, 1 case (1.7%) was cured clinically, 27 cases (45.0%) improved markedly, 26 cases (43.3%) improved, with a total effective rate of 90.0%. In the control group treated with Rheumatic Semen Strychni Tablets [symbol: see text], no case was cured, 16 cases (26.7%) improved markedly, 33 cases (55.0%) improved, with a total effective rate of 81.7%. Statistical data showed the Tong Luo Kai Bi Tablets had much better therapeutic effectiveness clinically than the Rheumatic Semen Strychni Tablets (P < 0.05).     

Treatment of nonspecific chronic prostatitis with Qian Lie Xian Yan Suppository suppository in 104 cases.

Qian Lie Xian Yan Suppository ([symbol: see text]) was rectally applied to treat 104 patients with nonspecific chronic prostatitis (damp-heat syndrome with blood stasis) in contrast to 30 patients treated with traditional Chinese drug Ye Ju Hua Shuan ([symbol: see text] Suppository of Flos Chrysanthemi Indici). The results show that chronic prostatitis is markedly improved by using Qian Lie Xian Yan suppository, with a short-term cure rate of 23.1% and a total effective rate of 84.6%, superior to that of the control group. The animal experiment indicates that Qian Lie Xian Yan suppository has better anti-inflammatory and analgesic effects, with an action of promoting blood circulation.     

Effects of Huang Qi Wu Wu Decoction on Plasma Proteins in 70 Cases of Chronic Pulmonary Heart Disease

Simple immune agar diffusion test was used to assay the contents of 12 plasma proteins in 70 cases ofchronic pulmonary heart disease treated by Huang Qi Wu Wu Decoction(黄芪五物汤),with theother 70 cases who were not given Huang Qi Wu Wu Decoction as the control group.The totalclinical effective rate in the treatment group was 90.0%,while that in the control group was 75.7%,with a statistically significant difference between the two groups(P<0.05).In the treatment group,thelevels of prealbumin,transferrin and fibronectin elevated obviously after treatment,and the contentsof C-reactive protein,ceruloplasmin,haptoglobin,α_1-antitrypsin and oh-acid glycoprotein decreasedmarkedly(P<0.01).In the control group,only the levels of ceruloplasmin and C-reactive proteindecreased significantly(P<0.05).It is shown that Huang Qi Wu Wu Decoction may enhance thetherapeutic effects for pulmonary heart disease,regulate the metabolism of plasma proteins,andimprove the life quality of the patients.     

TCM Treatment of Bronchial Asthma

Xuan Fei Ding Chuan Wan(宣肺定喘丸 pills for facilitating the flow of the lung-qi to relieve asthma)and Xiao Chuan Gu Ben Wan (哮喘固本丸 pills for treating asthma by consolidating the origin)wereused for treatment of bronchial asthma.The cure rate in the treated group(n=600)was 81.33%,significantly higher(P<0.01)than that in the control group(n=164,with a cure rate of 9.76%).     

One hundred and seven middle-aged and senile cases of coronary heart disease with ventricular premature beat treated by qing xin an shen fang.

The therapeutic principle of clearing away the heart-heat to induce tranquilization was adopted in 107 middle-aged and senile patients with ventricular premature beat of coronary heart disease on the basis of pathogenic features of phlegm, heat, blood stasis and deficiency in this condition. Qing Xin An Shen Fang ([symbol: see text] a formula for clearing away the heart-heat to induce tranquilization) was used in the treatment group and compared with mexiletine and Fu Fang Dan Shen Tablets ([symbol: see text] Compound Salvia Tablets) used in the control group. The results turned to be that the markedly effective rate was 85.1% and the total effective rate 96.3% in the treated group, better than that in the control group, with the former having a good antihypertensive and antihyperlipemic effect and an effect of improving microcirculation and clinical symptoms.     

步长健胃消炎颗粒治疗慢性非萎缩性胃炎临床观察

目的探讨步长健胃消炎颗粒治疗慢性非萎缩性胃炎的疗效。方法 160例慢性非萎缩性胃炎患者,随机分为两组。对照组采用胃乐新颗粒(冲剂)治疗;治疗组给予步长健胃消炎颗粒治疗。观察治疗前后临床有效率。结果治疗组总有效率为91.3%,对照组的总有效率为77.5%。两组治疗后总有效率比较差异有统计学意义(P<0.05)。结论步长健胃消炎颗粒治疗慢性非萎缩性胃炎,疗效显著,安全,副作用少,值得推广。     

Clinical Observation on the Method of Supplementing Qi, Clearing away Heat and Promoting Blood Circulation for Treating 53 Cases of Gastritis Related to Pyrolic Helicobacterium

According to the clinical experience of professor Shan Zhaowei (单兆伟), the author has successfully developed Qingyou Yangwei Capsule (清幽养胃胶囊capsules for eliminating pyrolic Helicobacterium and nourishing the stomach) for treating the gastritis. Clinical research has shown that the capsule has a good curative effect on chronic gastritis related to pyrolic Helicobacterium. Among the 53 cases in the treatment group, clinical observation showed cure in 6 cases, obvious effect in 18 cases, effect in 24 cases, no effect on 5 cases, with a total effective rate of 90.5%. Of the 50 cases in the control group, cure was found in 5 cases, obvious effect in 13 cases, effect in 20 cases, no effect in 12 cases, the total effective rate being 76%. The total effective rate in the treatment group was higher than that in the control group. The rate of eliminating pyrolic Helicobacterium in the treatment group was 66.04%, similar to that in the control group. In a follow-up visit 6 months later, the recurrence rate in the treatment group was 13.33%, obviously lower than that of 41.66% in the control group.     

Seventy-two Cases of Antidiabetic-Induced Hepatopathy Treated by Huatan Yigan Decoction

In order to observe the therapeutic effects of Huatan Yigan Decoction (化痰益肝汤 Decoction for resolving phlegm and replenishing the liver) on antidiabetic-induced hepatopathy, 129 cases were divided into two groups, 72 cases in the treatment group were administrated with Huatan Yigan Decoction and 57 cases in the control group with the liver-protecting drugs. Their liver function, plasma prothrombin time (PT), blood urea nitrogen and symptoms of the patients before and after treatment were observed during the three therapeutic courses. Results: The total effective rate and cured rate of the treatment group manifested an obvious difference in comparison with those of the control group (P＜0.05 or P＜0.01). Even though the liver function, blood urea nitrogen (BUN) and symptoms in both groups were improved markedly, these indicators in the treatment group were improved more markedly than those in control group (P＜0.01). No adverse effect was found during the treatment. Conclusion: Huatan Yigan Decoction shows a repair action on hepatic injury.     

补肺祛瘀汤治疗慢性阻塞性肺疾病稳定期临床观察

①目的观察运用补肺祛瘀汤治疗稳定期慢性阻塞性肺疾病（COPD）患者的疗效。②方法将符合纳入标准的70例COPD患者随机分为对照组,观察组各35例。对照组给予西医常规治疗,观察组在西医常规治疗的基础上加补肺祛瘀汤治疗。所有受试者治疗前后均进行临床症状评分、肺功能评价。治疗后分别进行临床症状疗效判定,记录不艮反应发生情况。③结果治疗后观察组与对照组总有效率分别为85．7l％和62．86％,有显著性差异（P〈0．05）;与对照组比较,观察组临床症状改善明显,但两组治疗前后肺功能比较均无差异（P〉0．05）。治疗过程中来发现不良反应。④结论补肺祛瘀汤改善稳定期慢性阻塞性肺疾病患者的临床症状,具有较好的临床疗效。     

An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage.

Large and small doses of drugs for improving blood circulation and removing blood stasis were used in model rats to treat mild chronic hepatic damage induced by carbon tetrachloride (CCl4). The results show that large dose of Dang Gui ([symbol: see text] Radix Angelicae Sinensis) and Dan Shen ([symbol: see text] Radix Salviae Miltiorrhizae) (drugs for regulating blood flow) and small dose of Yu Jin ([symbol: see text] Radix Curcumae) and Niu Xi ([symbol: see text] Radix Achyranthis Bidentatae) (drugs for activating blood flow) can significantly elevate the activity of SOD (P < 0.05) and/or lower the T/K ratio, markedly reduce the MDA content (P < 0.05 or P < 0.01) and significantly decrease the activities of ALT and AST (P < 0.05 or P < 0.01), demonstrating that these drugs are effective in combating oxygen free radicals (OFR) in chronic liver damage. On the contrary, large dose of Tu Bie Chong ([symbol: see text] Eupolyphaga seu Steleophaga) and E Zhu ([symbol: see text] Rhizoma Curcumae) (drugs for removing blood stasis) tend to increase the ALT and AST (P < 0.05) activities. The results suggest that the synergism of elevation of the SOD activity and reduction of T/K ratio contributes to the action of drugs for improving blood circulation and removing blood stasis in combating the liver damage induced by CCl4.     

Acupuncture Treatment of Chronic Superficial Gastritis by the Eight Methods of Intelligent Turtle

With the clinical manifestations and the point electric conduction volume as the indexes, the authors observed the immediate effects of the acupuncture treatment on chronic superficial gastritis with the points selected according to the date and time set by Ling Gui Ba Fa ([symbol: see text] Eight Methods of Intelligent Turtle), which was compared with the effects in the control group treated with the points selected according to syndrome-differentiation. A higher symptom improvement rate (P < 0.01) and a higher channel's balance-inverting rate were noticed in the former (P < 0.01), indicating that Ling Gui Ba Fa can give a better therapeutic results.     

Clinical study on treatment of chronic renal failure with shenshuailing.

The therapeutic effects of Shenshuailing Kou Fu Ye (SKFY [symbol: see text], the Oral Liquid for Renal Failure) and Shenshuailing Guan Chang Ye (SGCY [symbol: see text], the Enema for Renal Failure) were evaluated in treatment of chronic renal failure, with coateg aldehyde oxystarch as the controls. The changes in the clinical symptoms, serum creatinine, blood urea nitrogen and creatinine clearance rate were observed. The total effective rate in the former was 90.46%, and the latter 60.43%.     

痰热咳嗽颗粒治疗慢支痰热咳嗽的临床研究

目的：客观评价痰热咳嗽颗粒治疗慢支痰热咳嗽的临床疗效及其安全性，方法：采用随机单盲对照，治疗组用痰热咳嗽颗粒，对照组用急支颗粒，疗程均为１０ｄ。结果：治疗组总体疗效优于对照组；单项症状中，咯痰，胸闷，便秘３项症状的改善也优于对照组。实验室检查：治疗组治疗前后肺功能３项指标均有显著的改善；白细胞绝对值计数明显降低。安全性检查显示该药无明显的毒副作用。     

氨溴索联合干扰素γ雾化吸入治疗慢性支气管炎急性发作

目的：观察氨溴索联合干扰素γ雾化吸入法治疗慢性支气管炎急性发作的临床效果。方法：选取我院自2006年1月至2009年12月收治的慢性支气管炎急性发作的患者126例随机分为观察组（联合治疗组）和对照组（氨溴索治疗组）各63例,观察比较两组的治疗效果。结果：观察组痊愈32例,显效21例,有效10例,总有效率为84．1％;对照组痊愈11例,显效19例,有效26例,总有效率为47．7％。两组比较差异显著（P〈0．01）,具有统计学意义。两组在咳嗽咯痰、脓痰、呼吸困难等症状缓解时间比较上均有显著差异（P〈0．05）,具有统计学意义。结论：氨溴索联合干扰素γ雾化吸入法治疗慢性支气管炎急性发作效果理想,值得临床推广使用。     

博利康尼联合酮替芬治疗喘息型慢性支气管炎治疗体会

目的观察博利康尼与酮替芬联合使用对喘息型慢性支气管炎的疗效。方法选择喘息型慢性支气管炎104例,随机分成两组,治疗组56例,口服博利康尼（每次2．5mg,3次,d）与酮替芬（1mg,2次,d）;对照组48例,口服氨茶碱（0．1mg,3次,d）,其它辅助治疗方法相同,5d为1个疗程,连续应用2个疗程。结果治疗组总有效率分别达到96．43％。与对照组（72．92％）比较有极显著性差异（P〈0．01）。结论博利康尼与酮替芬联合使用对喘息型慢性支气管炎有良好的治疗作用。